Regeneron Pharmaceuticals (NQ:REGN)
571.54
+12.67
(+2.27%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 4, 2025
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 1,362,682 |
| Open | 566.98 |
| Bid (Size) | 565.00 (2) |
| Ask (Size) | 580.00 (1) |
| Prev. Close | 558.87 |
| Today's Range | 562.01 - 577.21 |
| 52wk Range | 476.49 - 1,211.20 |
| Shares Outstanding | 91,779,465 |
| Dividend Yield | 0.31% |
Top News
More News
Performance
More News
Read More
Regeneron (REGN) Q2 EPS Jumps 53%
August 02, 2025
Why Regeneron (REGN) Stock Is Trading Up Today
August 01, 2025
Regeneron's Pipeline Hit By Catalent Delays, But Dupixent Shines
August 01, 2025
Regeneron’s (NASDAQ:REGN) Q2: Strong Sales
August 01, 2025
Earnings Scheduled For August 1, 2025
August 01, 2025
Regeneron (REGN) Q2 Earnings: What To Expect
July 30, 2025
3 Low-Volatility Stocks We Steer Clear Of
July 24, 2025
1 Healthcare Stock on Our Buy List and 2 to Brush Off
July 15, 2025
Frequently Asked Questions
Is Regeneron Pharmaceuticals publicly traded?
Yes, Regeneron Pharmaceuticals is publicly traded.
What exchange does Regeneron Pharmaceuticals trade on?
Regeneron Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Regeneron Pharmaceuticals?
The ticker symbol for Regeneron Pharmaceuticals is REGN on the Nasdaq Stock Market
What is the current price of Regeneron Pharmaceuticals?
The current price of Regeneron Pharmaceuticals is 571.54
When was Regeneron Pharmaceuticals last traded?
The last trade of Regeneron Pharmaceuticals was at 08/04/25 04:00 PM ET
What is the market capitalization of Regeneron Pharmaceuticals?
The market capitalization of Regeneron Pharmaceuticals is 52.46B
How many shares of Regeneron Pharmaceuticals are outstanding?
Regeneron Pharmaceuticals has 52B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.